Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis

The new SARS-CoV-2 coronavirus is the causative agent of the COVID-19 pandemic outbreak that affected more than 190 countries worldwide with more than 292,000 confirmed cases and over 12,700 deaths. There is at the moment no vaccine or effective treatment for this disease which constitutes a serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakmi, Mohammed, Bouricha, El Mehdi, Kandoussi, Ilham, Harti, Jaouad El, Ibrahimi, Azeddine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Biomedical Informatics 2020
Materias:
Research-Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392094/
https://www.ncbi.nlm.nih.gov/pubmed/32773989
http://dx.doi.org/10.6026/97320630016301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392094/
https://www.ncbi.nlm.nih.gov/pubmed/32773989
http://dx.doi.org/10.6026/97320630016301

Ejemplares similares